文献速递头颈部肿瘤放疗

鼻咽癌放疗后六个月内早期转移预测列线图的建立与验证

Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
PubMed 文献 · Radiother Oncol · 2021-04-09

本研究基于9021例鼻咽癌患者建立并验证预测放疗后六个月内早期转移的列线图,训练集和验证集C-index分别为0.756和0.766,确定5.0%为临床决策阈值概率。

要点

  • 列线图预测鼻咽癌放疗后早期转移的C-index在训练集和验证集分别为0.756和0.766,优于任一独立因素。
  • 治疗前血浆EBV DNA、N分期、LDH、ALP、BMI和性别是早期转移的独立预测因素。
  • 选择5.0%作为阈值概率用于临床决策,可区分约85%的非早期转移患者和48%的早期转移患者。

核心结论

  • 列线图对鼻咽癌放疗后早期转移具有良好预测准确性,5.0%阈值适合临床决策。

研究设计与样本

  • 所有患者接受放疗联合或不联合化疗,采用单因素和多因素逻辑回归筛选独立风险因素。

主要发现

  • 训练集174例(2.9%)和验证集81例(2.7%)患者发生早期转移。
  • 治疗前血浆EBV DNA、N分期、LDH、ALP、BMI和性别是早期转移的独立预测因素。
  • 列线图C-index在训练集为0.756(95% CI=0.719-0.793),验证集为0.766(95% CI=0.720-0.813),显著优于任一独立因素。

关键数值与推荐

  • 基于概率密度函数和临床效用曲线并平衡真阳性早期转移与非早期转移患者,选择5.0%作为临床决策阈值概率。
  • 5.0%阈值可区分约85%的非早期转移患者和48%的早期转移患者。

临床怎么用

  • 利用治疗前血浆EBV DNA、N分期、LDH、ALP、BMI和性别计算列线图评分,评估鼻咽癌放疗后六个月内早期转移风险。
  • 以5.0%为阈值概率辅助临床决策,识别高危患者以指导强化治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to establish an effective prognostic nomogram to predict the risk of early metastasis (EM) in nasopharyngeal carcinoma (NPC) patients, as a guide for intensive treatment. MATERIALS AND METHODS: A total of 9021 patients with biopsy-confirmed NPC at our institute were enrolled in this study between December 2006 to December 2016. We randomized these patients using a proportion of 2/3 and 1/3 and selected 6044 and 2977 patients as the training and validation cohorts, respectively. All patients received radiotherapy with or without chemotherapy. Univariate and multivariate logistical regressions were used to identify independent risk factors. The nomogram's predictive value was evaluated by concordance indexes (C-indexes), calibration curves, probability density functions (PDFs), and clinical utility curves (CUCs). ROC analysis using Delong test was used to compare efficiency between the nomogram and other risk factors. RESULTS: In total, 174 (2.9%) and 81 (2.7%) patients in training and validation cohorts, respectively, had EM. Pretreatment plasma EBV DNA, N stage, LDH, ALP, BMI, and sex were independent predictive factors of EM. The C-indexes of nomogram were 0.756 (95% CI = 0.719-0.793) and 0.766 (95% CI = 0.720-0.813), in the training and validation cohorts, respectively. The C-index of the nomogram was significantly superior to any one of independent factors. According to the PDFs and CUCs and considering the balance of the true positive EM patients and true positive non-EM patients, we chose 5.0% as a threshold probability for clinical decision-making, which could distinguish about 85% and 48% of non-EM and EM patients, respectively. CONCLUSION: Our nomogram had good accuracy in predicting EM incidence, and a 5.0% threshold was appropriate for clinical decision-making.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lu ZJ, Liu LT, Sun XS, et al. Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment. Radiother Oncol. 2021. PMID: 33839207. doi:10.1016/j.radonc.2021.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。